As Alzheimer's disease and other dementias continue to rise nationwide, new research shows that equipping primary care ...
Angels on Call Homecare, the only healthcare provider in the United States holding dual accreditations in both dementia and Parkinson's care, has been named Best Employee Training Program in the 2026 ...
From financial woes to a declining sense of smell, issues that seem unrelated to memory can signal a dementia diagnosis in ...
Research reveals why Alzheimer’s brain damage doesn’t always lead to dementia, highlighting the role of protective brain ...
AUVELITY is a first-in-class treatment, which targets the NMDA and sigma-1 receptors, approved for agitation associated with dementia due to ...
In a major breakthrough, researchers have developed a simple blood test that may one day help doctors predict how fast ...
Adults with mild to moderate dementia with Lewy bodies had slowed decline in four clinical signals with the oral, ...
Too often people living with dementia are described as combative, aggressive, manipulative, difficult, or even accused of ...
Researchers identify the rostral prefrontal cortex as the essential bridge between spontaneous and executive brain networks ...
MedPage Today on MSN
FDA Approves First Non-Antipsychotic Drug for Alzheimer's Agitation
Oral NMDA receptor antagonist gets an expanded indication ...
The Food and Drug Administration (FDA) approved the drug Auvelity this week for the treatment of agitation in adults with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results